Owen A O’Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, talks about the Phase I trial (NCT01998035) looking into combining oral 5-azacitidine and romidepsin in patients with B-cell and T-cell lymphoma.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL.